Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00250328|
Recruitment Status : Unknown
Verified November 2005 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : November 8, 2005
Last Update Posted : November 8, 2005
The study involves adult subject requiring colonic anastomosis following laparoscopic intra-corporeal surgery. The anastomosis will be performed by using nitinilclip by the LapCAC device instead of staplers.
Endpoints: safety-Functioning secured anastomosis and no occurrence of adverse event related to device use.
The efficacy endpoint of this study includes clinical evaluation of characteristic parameters related to intestinal surgeries.
Discharge day (or ready-for-discharge) Proven anastomotic leak rate (clinically or radiological) Stenosis / stricture at anastomosis Patient recovery level will be assessed every day during hospitalization and in the follow up visits.
|Condition or disease||Intervention/treatment||Phase|
|Colon Cancer||Device: LapCAC Laparoscopic Compression Anastomosis Clip||Phase 1|
The following steps are to be performed during the NiTi LapCAC surgical procedure.
- Prophylactic antibiotic - as per specific department regimen.
- Bowel preparation will be performed one-day prior to surgery. The preparation will included Sofodex solution combined with oral neomycin.
- Aanticoagulation tratment prior surgery- as per specific department regimen.
- Routine general anesthesia according to standard operation room procedure.
- Prepare the surgery area according to routine procedure with soap and alcohol. Insert the trocars.
- Align the two ends of bowel side-by-side in the same direction or in the opposite direction. Seal the ends with staples leaving blind loop of no less than 2.5 cm. (1 inch) and make two small enterotomies.
- The Clip mounted on the Applier should be cooled by immersing it in ice-cold sterile saline bath for at least 20 seconds.
- Place the open clip into the prepared enterotomies, each clip coil in one enterotomy.
- Approximating body temperature, the coils will recover its programmed shape applying pressure on the tissue.
- Closure (staple line and enterotomies): closure of the enterotomies with or without suture inversion of staple lines will be done by using Vicryl suture 3-0 or other absorbable suture. Postoperative care will be as for conventional treatment.
- Post operative treatment will be according to the department regimen and in relation to the patient condition.
The following baseline variables will be recorded for all patients:
- Demographics, including: gender, age, race, weight and height (BMI), ASA status.
- Background of disease - presentation, and TNM stage, etc.
- Region of excised colon.
- Metastasis yes/no where.
Cardiac- (Ischemic heart disease (IHD), Congestive heart failure (CHF), NYHA Classification I,II,III,IV).
Respiratory- Asthma, Obstructive pulmonary disease (OPD). Diabetes- Type 1(insulin-dependent diabetes), Type 2 (non-insulin-dependent diabetes).
hepatic- Cirrhosis. Alcohol Smoking.
Follow-up evaluation will be performed every day during hospitalization and one-month, three months and six months post procedure.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy|
|Study Start Date :||January 2006|
- Functioning anastomosis without leaks or obstructions
- Functioning anastomosis without stenosis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00250328
|Contact: Ibrahim Matter, MDemail@example.com|
|Hadassah Medical Organization, Jerusalem, Israel||Not yet recruiting|
|Contact: Arik Tzukert,, DMD 00 972 2 6776095 firstname.lastname@example.org|
|Contact: Hadas Lemberg, PhD 00 972 2 6777572 email@example.com|
|Principal Investigator: Nacum Beglibter|
|Principal Investigator:||Ibrahim Matter, MD||Benei-Zion Medical Center|